April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Macular Function Evaluated by Focal Macular Electroretinograms after Reduced Fluence Photodynamic Therapy in Eyes with Poplypoidal Choroidal Vasculopathy
Author Affiliations & Notes
  • Shigeki Machida
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Kunifusa Tamada
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Tomoharu Nishimura
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Takamitsu Fujiwara
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Daisuke Yokoyama
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Daijiro Kurosaka
    Ophthalmology, Iwate Medical University School of Medicine, Morioka, Japan
  • Footnotes
    Commercial Relationships  Shigeki Machida, None; Kunifusa Tamada, None; Tomoharu Nishimura, None; Takamitsu Fujiwara, None; Daisuke Yokoyama, None; Daijiro Kurosaka, None
  • Footnotes
    Support  Grant-in-Aid for Scientific Research C from Ministry of Education, Science, and Culture in Japan No. 20592056
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3505. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shigeki Machida, Kunifusa Tamada, Tomoharu Nishimura, Takamitsu Fujiwara, Daisuke Yokoyama, Daijiro Kurosaka; Macular Function Evaluated by Focal Macular Electroretinograms after Reduced Fluence Photodynamic Therapy in Eyes with Poplypoidal Choroidal Vasculopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3505.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the macular function by the focal macular electroretinograms (ERGs) after reduced fluence photodynamic therapy (RFPDT) in Japanese patients with polypoidal choroidal vasculopathy.

Methods: : We studied 12 eyes of 12 patients with PCV in which the diameter of the lesion was less than 3,500 µm. Their ages ranged 62 to 85 years with a mean of 75 years. The exposure time was reduced to 42 sec so that the total energy of the laser was approximately one-half of the standard PDT dosage. We measured the visual acuity, foveal thickness, and focal macular ERGs before and after the RFPDT. The focal macular ERGs were elicited by a 15° white stimulus spot centered on the macula. The rate of recurrence of exudative changes was determined one year after the RFPDT.

Results: : The visual acuities improved gradually postoperatively. A significant recovery of vision was seen even at 1 week after RFPDT (P<0.05). The foveal thickness was reduced even 1 week after the treatment (P<0.005), and became significantly thinner with increasing time (P<0.05). The amplitudes of the a- and b-waves were significantly reduced with significantly prolonged implicit times at the baseline compared to the unaffected normal fellow eyes. A slight recovery of the a- and b-wave amplitudes was seen postoperatively without a transient reduction of the amplitudes. The b-wave amplitude was significantly larger at 3 months after the treatment (P<0.05). Indocyanine green angiography showed that choroidal hypoperfusion did not develop 3 months postoperatively. A recurrence of the exudative changes was detected in 6 out of 12 eyes, and these required additional treatments.

Conclusions: : RFPDT provides short-term benefits in PCV patients with small lesions. Maintenance of the macular function was achieved after RFPDT without the transient decrease of function. These findings indicate that RFPDT can be used to treat PCV patients with relative good vision.

Keywords: electroretinography: clinical • age-related macular degeneration • photodynamic therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×